These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 8797620)
21. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. Lindsay CA; Barton P; Lawless S; Kitchen L; Zorka A; Garcia J; Kouatli A; Giroir B J Pediatr; 1998 Feb; 132(2):329-34. PubMed ID: 9506650 [TBL] [Abstract][Full Text] [Related]
22. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. Doolan LA; Jones EF; Kalman J; Buxton BF; Tonkin AM J Cardiothorac Vasc Anesth; 1997 Feb; 11(1):37-41. PubMed ID: 9058218 [TBL] [Abstract][Full Text] [Related]
23. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure. Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794 [TBL] [Abstract][Full Text] [Related]
24. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside]. Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922 [TBL] [Abstract][Full Text] [Related]
25. Haemodynamic and biological effects of intravenous milrinone in patients with a low cardiac output syndrome following cardiac surgery: multicentre study. George M; Lehot JJ; Estanove S Eur J Anaesthesiol Suppl; 1992; 5():31-4. PubMed ID: 1600967 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Bailey JM; Levy JH; Kikura M; Szlam F; Hug CC Anesthesiology; 1994 Sep; 81(3):616-22. PubMed ID: 8092507 [TBL] [Abstract][Full Text] [Related]
27. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States. Anderson JL Am Heart J; 1991 Jun; 121(6 Pt 2):1956-64. PubMed ID: 2035427 [TBL] [Abstract][Full Text] [Related]
28. Modulation of venous tone in heart failure. Muir AL; Nolan J Am Heart J; 1991 Jun; 121(6 Pt 2):1948-50. PubMed ID: 2035425 [TBL] [Abstract][Full Text] [Related]
29. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index. Yamada T; Takeda J; Katori N; Tsuzaki K; Ochiai R J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598 [TBL] [Abstract][Full Text] [Related]
30. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425 [TBL] [Abstract][Full Text] [Related]
31. Beneficial hemodynamic effects of two weeks' milrinone treatment in conscious rats with heart failure. Schoemaker RG; Debets JJ; Struyker-Boudier HA; Smits JF Eur J Pharmacol; 1990 Jul; 182(3):527-35. PubMed ID: 2226621 [TBL] [Abstract][Full Text] [Related]
32. Milrinone in the treatment of chronic cardiac failure: a controlled trial. Likoff MJ; Weber KT; Andrews V; Janicki JS; Wilson H; Rocci ML Am Heart J; 1985 Nov; 110(5):1035-42. PubMed ID: 3904373 [TBL] [Abstract][Full Text] [Related]
33. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients. Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238 [TBL] [Abstract][Full Text] [Related]
34. Cardiac and hemodynamic effects of intravenous R80122, a new phosphodiesterase III inhibitor, in a canine model of myocardial ischemia and heart failure. Van de Water A; Xhonneux R; Reneman RS; Janssen PA J Cardiovasc Pharmacol; 1992 Jul; 20(1):18-24. PubMed ID: 1383627 [TBL] [Abstract][Full Text] [Related]
35. [Efficacy of intravenous milrinone in the treatment of acute congestive cardiac failure. Results of a French multicenter study]. Dubois-Randé JL; Guérot C; Jan F; Brochier M; Sacrez A; Vacheron A; Bory M; Lambert H; Pony JC; Le Bloc'h Y Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):105-14. PubMed ID: 8494318 [TBL] [Abstract][Full Text] [Related]
37. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group. Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534 [TBL] [Abstract][Full Text] [Related]
38. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure]. Boesch C; Dubois-Rande JL; Pochmalicki G; Lellouche D; Teiger E; Saal JP; Cachin JC; Mallo C; Castaigne A; Jan F Ann Cardiol Angeiol (Paris); 1992 Nov; 41(9):509-12. PubMed ID: 1298193 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic achievements of phosphodiesterase inhibitors and the future. Jewitt DE Eur Heart J; 1989 Aug; 10 Suppl C():53-9. PubMed ID: 2680498 [TBL] [Abstract][Full Text] [Related]
40. Hemodynamic and regional blood flow response to milrinone in patients with severe congestive heart failure: a dose-ranging study. Fitzpatrick PG; Cinquegrani MP; Vakiener AR; Baggs JG; Biddle TL; Liang CS; Hood WB Am Heart J; 1987 Jul; 114(1 Pt 1):97-105. PubMed ID: 3604878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]